Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
bias decrease » sizes decrease (Expand Search), bias increases (Expand Search), a decrease (Expand Search)
Showing 1,841 - 1,860 results of 21,342 for search '(( significant ((bias decrease) OR (mean decrease)) ) OR ( significant decrease decrease ))', query time: 0.55s Refine Results
  1. 1841
    IFA effectively limited bacterial dissemination and protected mice from lethal hypervirulent <i>K</i>. <i>pneumoniae</i> pneumonia.

    IFA effectively limited bacterial dissemination and protected mice from lethal hypervirulent <i>K</i>. <i>pneumoniae</i> pneumonia. by Tingting Wang (123983)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1842
    IFA reduced the virulence of hypervirulent <i>K</i>. <i>pneumoniae</i> in <i>G</i>. <i>mellonella</i> larvae.

    IFA reduced the virulence of hypervirulent <i>K</i>. <i>pneumoniae</i> in <i>G</i>. <i>mellonella</i> larvae. by Tingting Wang (123983)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1843
    IFA reduced the capsular biosynthesis through altering bacterial metabolism.

    IFA reduced the capsular biosynthesis through altering bacterial metabolism. by Tingting Wang (123983)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1844
    IFA effectively reduced the production of <i>K</i>. <i>pneumoniae</i> capsule.

    IFA effectively reduced the production of <i>K</i>. <i>pneumoniae</i> capsule. by Tingting Wang (123983)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1845
    IFA disarmed capsule-mediated immune evasion.

    IFA disarmed capsule-mediated immune evasion. by Tingting Wang (123983)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1846
    IFA abrogated capsule-associated hypermucoviscosity phenotypes of hypervirulent <i>K</i>. <i>pneumoniae</i>.

    IFA abrogated capsule-associated hypermucoviscosity phenotypes of hypervirulent <i>K</i>. <i>pneumoniae</i>. by Tingting Wang (123983)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1847
    Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>.

    Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 1848
    IFA sensitized hypervirulent <i>K</i>. <i>pneumoniae</i> to complement-mediated killing by inhibiting capsule.

    IFA sensitized hypervirulent <i>K</i>. <i>pneumoniae</i> to complement-mediated killing by inhibiting capsule. by Tingting Wang (123983)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1849
    Validation of distinct contribution of capsule and hypercapsule-associated HMV in IFA-conferred protection against hvKP infection using a <i>ΔrmpD</i>-K7 mutant.

    Validation of distinct contribution of capsule and hypercapsule-associated HMV in IFA-conferred protection against hvKP infection using a <i>ΔrmpD</i>-K7 mutant. by Tingting Wang (123983)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1850
    Schematic diagram summarizing the overall mechanism of action.

    Schematic diagram summarizing the overall mechanism of action. by Haotian Ma (11100492)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1851
    Effects of PCM7−4 on the relative expression of genes associated with biofilm formation.

    Effects of PCM7−4 on the relative expression of genes associated with biofilm formation. by Haotian Ma (11100492)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1852
    Effects of bacteriocin PCM7−4 on bacteria within the biofilm in <i>L. monocytogenes.</i>

    Effects of bacteriocin PCM7−4 on bacteria within the biofilm in <i>L. monocytogenes.</i> by Haotian Ma (11100492)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1853
    The impact of bacteriocin PCM7−4 on the formation of <i>L. monocytogenes</i> biofilms was observed using SEM.

    The impact of bacteriocin PCM7−4 on the formation of <i>L. monocytogenes</i> biofilms was observed using SEM. by Haotian Ma (11100492)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1854
    List of primers used in this study.

    List of primers used in this study. by Haotian Ma (11100492)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1855
    Effects of bacteriocin PCM7−4 on the quantification of biofilm formation in <i>L. monocytogenes.</i>

    Effects of bacteriocin PCM7−4 on the quantification of biofilm formation in <i>L. monocytogenes.</i> by Haotian Ma (11100492)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1856
    Effects of bacteriocin PCM7−4 on motility in <i>L. monocytogenes.</i>

    Effects of bacteriocin PCM7−4 on motility in <i>L. monocytogenes.</i> by Haotian Ma (11100492)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1857
    Effects of bacteriocin PCM7−4 on the exopolysaccharide production in <i>L. monocytogenes.</i>

    Effects of bacteriocin PCM7−4 on the exopolysaccharide production in <i>L. monocytogenes.</i> by Haotian Ma (11100492)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1858
    Growth curve of L. monocytogenes exposed to bacteriocin PCM7−4.

    Growth curve of L. monocytogenes exposed to bacteriocin PCM7−4. by Haotian Ma (11100492)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1859
    Location, timing, and size of the European outbreaks.

    Location, timing, and size of the European outbreaks. by Albertus Constantijn Sloof (20405090)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 1860
    Overview of the parameters used in the model.

    Overview of the parameters used in the model. by Albertus Constantijn Sloof (20405090)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: